VERITON-CT at Institut Gustave Roussy Paris

At Institut Gustave Roussy, one of Europe’s leading cancer centers, innovation in oncology is deeply connected to patient care.

In this exclusive report, we enter the world of theranostics—where diagnosis and treatment come together in a single, highly personalized approach.

We meet Désirée Deandreis and her team, who are actively using theranostic strategies to not only detect disease with precision, but also to directly treat patients using targeted radioligand therapies.

From advanced molecular imaging to individualized treatment pathways, their work illustrates how nuclear medicine is transforming the way cancer is managed—bringing more precision, more personalization, and new hope to patients.

This is a closer look at a rapidly evolving field where imaging truly guides therapy, and where every patient benefits from a tailored approach to care.